X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (26) 26
humans (25) 25
female (18) 18
male (18) 18
aged (17) 17
infectious diseases (17) 17
middle aged (17) 17
risk factors (17) 17
adult (16) 16
cancer (16) 16
mortality (15) 15
epidemiology (14) 14
neutropenia (14) 14
risk-factors (13) 13
bacteremia (12) 12
microbiology (12) 12
anti-bacterial agents - therapeutic use (10) 10
cancer patients (10) 10
neoplasms - complications (10) 10
antibiotics (9) 9
bloodstream infection (9) 9
infectious disease (9) 9
patients (9) 9
bacteremia - drug therapy (8) 8
bacteremia - microbiology (8) 8
blood-stream infections (8) 8
therapy (8) 8
treatment outcome (8) 8
aged, 80 and over (7) 7
hospitals (7) 7
infections (7) 7
aspergillosis (6) 6
bacteremia - epidemiology (6) 6
prevention (6) 6
young adult (6) 6
adolescent (5) 5
analysis (5) 5
care and treatment (5) 5
dosage and administration (5) 5
enterobacteriaceae infections - drug therapy (5) 5
escherichia-coli (5) 5
hematology (5) 5
immunology (5) 5
impact (5) 5
malalts de càncer (5) 5
medicine (5) 5
prospective studies (5) 5
research (5) 5
resistance (5) 5
retrospective studies (5) 5
anti-infective agents (4) 4
antifungal agents (4) 4
antifungal agents - therapeutic use (4) 4
antimicrobial resistance (4) 4
bacteraemia (4) 4
bacteremia - complications (4) 4
catheters (4) 4
catèters (4) 4
complications and side effects (4) 4
drug resistance, multiple, bacterial (4) 4
drug therapy (4) 4
enterobacteriaceae - drug effects (4) 4
febrile neutropenia (4) 4
gram-negative bacilli (4) 4
guidelines (4) 4
health aspects (4) 4
infeccions (4) 4
infection (4) 4
medical personnel (4) 4
multidisciplinary sciences (4) 4
multivariate analysis (4) 4
neoplasms - microbiology (4) 4
patient outcomes (4) 4
pharmacology & pharmacy (4) 4
pneumonia (4) 4
research article (4) 4
science (4) 4
spain - epidemiology (4) 4
stem cells (4) 4
tratamiento (4) 4
tumors (4) 4
voriconazole (4) 4
agents antiinfecciosos (3) 3
antibiotic resistance (3) 3
antimicrobial therapy (3) 3
anàlisi per injecció en flux (3) 3
bacteremia - mortality (3) 3
bacterial infections and mycoses (3) 3
bacterial pneumonia (3) 3
beta-lactams - therapeutic use (3) 3
candidemia (3) 3
candidemia - microbiology (3) 3
carbapenemasas (3) 3
carbapenemases (3) 3
carbapenems (3) 3
carbapenems - therapeutic use (3) 3
cell transplant recipients (3) 3
clinical trials (3) 3
diagnosis (3) 3
drug resistance (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, p. e0185768
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2013, Volume 8, Issue 9, p. e74734
We conducted a prospective study to assess the risk factors, molecular epidemiology and outcome of bloodstream infection (BSI) due to Enterococcus faecium in... 
MORTALITY | BACTEREMIA | MULTIDISCIPLINARY SCIENCES | MALIGNANCIES | FAECALIS | VIRULENCE | EMERGENCE | RESISTANT ENTEROCOCCI | Enterococcus faecium - drug effects | Prospective Studies | Humans | Middle Aged | Risk Factors | Male | Enterococcus faecium - genetics | Patient Outcome Assessment | Multilocus Sequence Typing | Bacteremia | Gram-Positive Bacterial Infections - epidemiology | Incidence | Enterococcus faecium - classification | Young Adult | Neoplasms - complications | Vancomycin - pharmacology | Gram-Positive Bacterial Infections - microbiology | Hematopoietic Stem Cell Transplantation - adverse effects | Aged, 80 and over | Adult | Female | Aged | Gram-Positive Bacterial Infections - complications | Drug resistance in microorganisms | Medical research | Usage | Patient outcomes | Disease susceptibility | Research | Vancomycin | Epidemiology | Risk factors | Infection | Cancer patients | Ampicillin | Medicine, Experimental | Corticoids | Therapy | Corticosteroids | Mortality | Neutrophils | Health risks | Antimicrobial agents | Infections | Risk analysis | Patients | Ethics | Infectious diseases | Antibiotics | Genotyping | Antibiotic resistance | Emergence | Ciprofloxacin | Carbapenems | Glycopeptides | Cancer | Estreptococs | Càncer | Streptococcus | Administració de medicaments | Bacterial diseases | Infeccions | Administration of drugs | Malalties bacterianes
Journal Article
Current opinion in critical care, ISSN 1070-5295, 07/2019, Volume 25, Issue 5, pp. 438 - 448
Infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) are increasing worldwide. Carbapenems are usually regarded as the... 
Journal Article
Current Opinion in Critical Care, ISSN 1070-5295, 10/2019, Volume 25, Issue 5, p. 438
RECENT FINDINGS: Meropenem and imipenem are the drugs recommended for treatment of ESBL BSIs in critically ill patients, and in infections with high bacterial... 
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2015, Volume 10, Issue 3, p. e0120370
Journal Article
Journal Article
ISSN 1932-6203, 10/2017
Objectives: To assess the current incidence, clinical features, risk factors, aetiology, antimicrobial resistance and outcomes of polymicrobial bloodstream... 
Cancer patients | Agents antiinfecciosos | Flow injection analysis | Malalts de càncer | Anti-infective agents | Anàlisi per injecció en flux
Journal Article
ISSN 1932-6203, 10/2017
Objectives: To assess the current incidence, clinical features, risk factors, aetiology, antimicrobial resistance and outcomes of polymicrobial bloodstream... 
Cancer patients | Agents antiinfecciosos | Flow injection analysis | Malalts de càncer | Anti-infective agents | Anàlisi per injecció en flux
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 3/2014, Volume 22, Issue 3, pp. 603 - 610
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 02/2019, Volume 68, Issue 5, pp. 890 - 890
Journal Article
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ISSN 1058-4838, 01/2019
Mortality rates from Staphylococcus aureus bacteremia are high and have only modestly improved in recent decades. We compared the efficacies of beta-lactam in... 
Journal Article
MYCOSES, ISSN 0933-7407, 06/2019, Volume 62, Issue 6, pp. 526 - 533
Background Posaconazole (PCZ) is used mainly for the prevention of invasive fungal infection (IFI). Methods A multicentre retrospective, investigational study... 
posaconazole | VORICONAZOLE | refractory therapy | GUIDELINES | ORAL SUSPENSION | OPEN-LABEL | INVASIVE FUNGAL-INFECTIONS | AMPHOTERICIN-B | TABLET | intolerant therapy | yeast | DERMATOLOGY | aspergillosis | DISEASE | ANTIFUNGAL AGENTS | zygomycosis | MYCOLOGY | salvage therapy | Serum levels | Tablets | Toxicity | Aspergillosis | Posaconazole | Patients | Zygomycosis
Journal Article
Journal Article
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ISSN 1058-4838, 04/2019
We aimed to describe the current rates of inappropriate empirical antibiotic treatment (IEAT) in oncohematological patients with febrile neutropenia (FN) and... 
Journal Article